HELSINKI and NAPLES, Italy, April 09, 2025 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), an immunotherapy company developing novel, adaptable treatments for cancer, today announced the appointment of Marcella Origgi as its Chief Executive Officer (CEO) of its Helsinki headquarters and Naples subsidiary. Marcella joins from Johnson & Johnson Innovation and is an accomplished leader…
Tue, 08 Apr 2025 17:00:00 GMT HELSINKI and NAPLES, Italy, April 09, 2025 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), an immunotherapy company developing ... Marcella joins from Johnson & Johnson Innovation and is an ...